Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent.
about
Neuronal seipin knockout facilitates Aβ-induced neuroinflammation and neurotoxicity via reduction of PPARγ in hippocampus of mouseEnvironmental immune disruptors, inflammation and cancer riskPeroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal functionLoss of the SIN3 transcriptional corepressor results in aberrant mitochondrial function.PPARalpha is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesisMolecular Characterization of the Onset and Progression of Colitis in Inoculated Interleukin-10 Gene-Deficient Mice: A Role for PPARalphaThe Role of PPARα Activation in Liver and Muscle.Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease.Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs.PPARγ signaling is required for mediating EETs protective effects in neonatal cardiomyocytes exposed to LPSResearch resource: Comparative nuclear receptor atlas: basal and activated peritoneal B-1 and B-2 cells.A role for the peroxisome proliferator-activated receptor alpha in T-cell physiology and ageing immunobiology.PPAR and immune system--what do we know?Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationTranscriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.PPARalpha in atherosclerosis and inflammation.Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation.Combinatorial roles of nuclear receptors in inflammation and immunity.PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis.PPARs and molecular mechanisms of transrepressionLoss of PPARα perpetuates sex differences in stroke reflected by peripheral immune mechanisms.Sex differences and the role of PPAR alpha in experimental stroke.The role of the circadian clock in rheumatoid arthritis.Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology.Stem cells, phenotypic inversion, and differentiation.Pharmacogenetics of the PPAR genes and cardiovascular disease.Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related InflammationNuclear receptors and inflammatory diseases.Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's DiseaseSex differences in the immune response to experimental stroke: Implications for translational research.Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease.The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases.The role of PPARγ-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology.The SIN3 deacetylase complex represses genes encoding mitochondrial proteins: implications for the regulation of energy metabolism.Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease.Sex-specific regulation of immune responses by PPARs.Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886.
P2860
Q27303098-978EF5C6-D49D-413F-B32E-007DEDA36D8AQ28080870-ACEE3CA3-F548-4DDD-8E2E-5314803CF983Q28566540-AB44B271-3B71-4868-8000-4904BE3DC4D3Q33629464-954C3945-1ED7-4F70-86D2-245A8E454552Q33682146-BBEAA17E-06DF-448C-AC2F-C3F9BBDB3CA1Q34021941-8F464659-5FA3-414F-809C-76522E756358Q34106233-4B9E2A0E-AC55-4622-8957-F05C4296A286Q34222727-A4B4AC01-C3E5-4862-B525-A38D3ED5497EQ34460512-E13CD998-DF0F-47EC-89F8-439AB926D483Q34488280-999B48DA-54CB-49C7-9F51-4A12ABB2DAE7Q34609943-AC5F3CC0-1CD7-40D6-9C10-19324BA4982AQ34892990-3FD9C139-B5C1-4AAD-A858-95788231874DQ34913467-74B97AFD-81C1-4120-AD07-FA116C214818Q35021504-7882EA91-8D6E-4611-8FE4-79903BA7EE48Q35053566-D676AEDF-AA51-4605-B52F-7B68487FC2C1Q35228774-A58DB080-7912-4A66-8622-C45FD8584645Q36154953-77EED902-266C-44CD-BDF5-18FC3337B465Q36371379-1B0BCFCD-905E-4094-850C-A1F54176A3BEQ36403404-7B62051E-76C6-4CA0-8A00-2740BDD81D5CQ36528512-42E6D229-A78A-45F0-AEF1-338150F0C1E0Q36591722-D47F3D7C-DF46-4804-89F2-560D3DC29117Q36767657-B5B7DC7C-6EF1-42A8-B088-543224061BFBQ36791361-A3C02071-A56C-474F-93E6-FD8CA067381AQ36892763-4EC740E5-C4CE-4EE0-A8AF-CAC38608C9B1Q36892933-1BB0CA98-2143-46DE-8C1A-81DC32137E6EQ36903114-7EF2395A-DB45-4AEC-9D34-846CD42C55ABQ36943169-104AED83-331A-4CF9-961A-2ADD8566E373Q37000173-567E3728-2B6D-4136-A1AB-A4D17CBF74E2Q37012017-D9E6FD4B-BDA8-425A-A9BF-EC7260D7A2DEQ37114625-3A0A626B-E75B-4F9F-970F-1FAE74813A20Q37122891-F3D3702C-FAA8-4B33-98DC-9A76CC067F12Q37211800-1DAC461F-F715-4A14-8FFD-53C2C2AA645DQ37432327-E552440E-3408-469B-922C-30EF234E2891Q37447470-DF5EB94B-8F76-4EBF-A6AB-3980564DD88AQ37989830-286A5240-48FE-45AD-B488-9AFC7BA0857BQ38341507-AAE822DF-0297-4CD0-B2A6-0297EDCD9E5FQ38352502-98846B61-5B23-4ECF-8CDD-0DC783C54DD9Q39780799-2AB52D99-AB3F-4BE2-B0B7-94BD32143B17Q40107299-05B6AC52-8E09-4962-B5CD-60298BB7B822Q42183913-F023B65C-BF8F-4CA4-9188-2F0DC163DC44
P2860
Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Nuclear receptor peroxisome pr ...... and transrepression competent.
@en
type
label
Nuclear receptor peroxisome pr ...... and transrepression competent.
@en
prefLabel
Nuclear receptor peroxisome pr ...... and transrepression competent.
@en
P2093
P2860
P356
P1476
Nuclear receptor peroxisome pr ...... and transrepression competent.
@en
P2093
Dallas C Jones
Raymond A Daynes
Xiaohong Ding
P2860
P304
P356
10.1074/JBC.M106908200
P407
P577
2001-11-28T00:00:00Z